Federal Register / Vol. 74, No. 69 / Monday, April 13, 2009 / Notices 16877 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 7, 2009. 

Elaine L. Baker, 

Management Analysis and Services Office, 

Centers for Disease Control and Prevention. 

[FR Doc. E9–8330 Filed 4–10–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): CDC Grants for 

Public Health Research Dissertation, 

Panel C, Funding Opportunity 

Announcement (FOA) PAR07–231 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 

9 a.m.–5 p.m., April 28, 2009 (Closed). 

9 a.m.–5 p.m., April 29, 2009 (Closed). 

Place: W Hotel, 188 14th Street, NE., 

Atlanta, Georgia 30361, Telephone: (404) 

892–6000. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘CDC Grants for Public Health 

Research Dissertation, Panel C, FOA PAR07– 

231.’’ 

Contact Person for More Information: 

Christine J. Morrison, PhD, Scientific Review 

Officer, Office of the Director, Office of the 

Chief Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–3098. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 7, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–8333 Filed 4–10–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

Coordinating Center for Infectious 

Diseases (CCID) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., May 14, 2009. 

8:30 a.m.–3:30 p.m., May 15, 2009. 

Place: CDC Global Communication Center, 

Building 19, 1600 Clifton Road, NE., Atlanta, 

Georgia 30333. 

May 14, 2009—Building 19; Working 

Groups will meet as follows: 

Rooms 245/246—The National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP). 

Rooms 247/248—National Center for 

Zoonotic, Vector-Borne, and Enteric Diseases 

(NCZVED). 

Rooms 254/255—National Center for 

Immunization and Respiratory Diseases 

(NCIRD). 

Rooms 256/257—National Center for 

Preparedness, Detection, and Control of 

Infectious Diseases (NCPDCID). 

May 15, 2009—Full Board meets in 

Auditorium B3. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The Board of Scientific 

Counselors, CCID, provides advice and 

guidance to the Director, CDC, and Director, 

CCID, in the following areas: program goals 

and objectives; strategies; program 

organization and resources for infectious 

disease prevention and control; and program 

priorities. 

Matters to be Discussed: Agenda items will 

include: 

1. Breakout Group Discussions: 

Environmental Microbiology—morning 

session (NCPDCID and NCZVED). 

2. Strategic Plan (NCPDCIC)—afternoon 

session. 

3. Strategic Blueprint (NCZVED)— 

afternoon session. 

4. Strategic Plan (NCHHSTP). 

5. Prevention of Neonatal Group B 

Streptococcal Disease Influenza at the 

Human-Animal Interface; Review of 

Recommendations from April 2009 

Meeting—(NCIRD). 

6. Strategies for Infectious Diseases; 

Positioning for the Future (Full Board). 

7. Budget and CCID/OD Updates. 

Other agenda items include 

announcements/introductions; follow-up on 

actions recommended by the Board and 

consideration of future directions, goals, and 

recommendations. 

Agenda items are subject to change as 

priorities dictate. 

Written comments are welcome and should 

be received by the contact person listed 

below prior to the opening of the meeting. 

Contact Person for More Information: 

Harriette Lynch, Office of the Director, CCID, 

CDC, Mailstop E–77, 1600 Clifton Road, N.E., 

Atlanta, Georgia 30333, e-mail: 

hlynch@cdc.gov; telephone (404) 498–2726. 

The Director, Management Analysis and 

Services office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 6, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–8342 Filed 4–10–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director, 

Centers for Disease Control (ACD, 

CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), CDC announces the 

following meeting of the 

aforementioned committee: 

Time and Date: 8 a.m.–3:30 p.m., April 30, 

2009. 

Place: Centers for Disease Control and 

Prevention, Tom Harkin Global 

Communications Center, Kent ‘‘Oz’’ Nelson 

Auditorium, 1600 Clifton Road, NE., Atlanta, 

Georgia 30333. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 150 people. 

Purpose: The committee will provide 

advice to the Director, CDC on strategic and 

other broad issues facing CDC. 

Matters To Be Discussed: The committee 

will discuss the final report on the 

recommendations from the National 

Biosurveillance Advisory Subcommittee; 

discuss the mission of the Health Disparities 

Subcommittee; discuss the recommendations 

from the Ethics Subcommittee on the 

‘‘Ethical Aspects of Compulsory Use of 

Travel Restriction Tools’’, and the 

subcommittee’s input on the ‘‘Role of Social 

Determinants Health in Health Reform’’; and 

will discuss CDC’s Organizational Review. 

Agenda items are subject to change as 

priorities dictate. 

For Further Information Contact: Brad 

Perkins, M.D., M.B.A., ACD, CDC, 1600 

Clifton Road, NE., M/S D–14, Atlanta, 

Georgia 30333. Telephone 404–639–7000. 

The Director, Management Analysis and 

Services office has been delegated the 

authority to sign Federal Register notices